OLANZAPINE Comprimé

Pays: Canada

Langue: français

Source: Health Canada

Ingrédients actifs:

Olanzapine

Disponible depuis:

SIVEM PHARMACEUTICALS ULC

Code ATC:

N05AH03

DCI (Dénomination commune internationale):

OLANZAPINE

Dosage:

10MG

forme pharmaceutique:

Comprimé

Composition:

Olanzapine 10MG

Mode d'administration:

Orale

Unités en paquet:

100/500

Type d'ordonnance:

Prescription

Domaine thérapeutique:

ATYPICAL ANTIPSYCHOTICS

Descriptif du produit:

Numéro de groupe d'ingrédients actifs (GIA) :0128783002; AHFS:

Statut de autorisation:

APPROUVÉ

Date de l'autorisation:

2012-06-05

Résumé des caractéristiques du produit

0RQRJUDS LHGHSURGLW 2/ 1
3,1(
3DJH
GH
0212*5 3,((3528,7
3U
2/1= 3,1(
RPSULPpV GRODQ]DSLQH 863
PJ
PJ
PJ
PJ
PJ PJ
QWLSV FKRWLTXH
ZZZVLYHPFD
5 3
6DLQW /DXUHQW 4XpEHF
UXH
REULQ
6LYHP 3URGXLWV3KDUPDFHXWLTXHV 8/
1
R
GH FRQWUOHGHOD SUpVHQWDWLRQ
GpFHPEUH
DHGH UpLVLRQ
0RQRJUDS LHGHSURGLW 2/ 1
3,1(
3DJH
GH
7DEOHGHV PDLqUHV
37,( ,
,1 2 07,216(67,1e(6
8; 32 (66,211(/6
( /617e
6200 ,5((6,1)250 7,216685 /(3528,7
,1,
7,216(786
*(/,1,48(
2175( ,1,7,216
0,6(6(1*5 ((7 35e 87,216
5e7,216,1e6,5 %/(6
,17(5
7,2160e,
0(17(86(6
3262/2*,((70,1,675 7,21C
685 26*(
02 (
7,21(7 3502/2*,(/,1,48(
51*(0(17(767%,/,7e
)250(6 3
50(87,48(620326,7,21(7
21 ,7,211(0(17
3
7,( ,,
,1 2 0 7,2166,(17,,48(6
,1)250 7,216 350(87,48(6
(66,6/,1,48(6
350
2/2*,(
e7 ,//e(
72;,
2/2*,(
5e)e5(1(6
37,( ,,,
,12 0 7,216
(67,1e(68;
2162007(86
0RQRJUDS LHGHSURGLW 2/ 1
3,1(
3DJH
GH
3U
2/1=3,1(
RPSULPpV GRODQ]DSLQH 863
37,( ,
,1207,216(67,1e(6
8;32 (66,211(/6
( /617e
6200 ,((6 ,1 2 0 7,216 68/( 328,7
3URGXL
9RLH
GDGPLQLV UDLRQ
RUPH
7HQHXU
,QJUpGLHQV QRQ PpGLFLQDX
2/1=3,1(
2UDOH
RPSULPpV
PJ
PJ
PJ
PJ
PJ
PJ
/HVFRPSULPpVGH PJ PJ
PJ
PJ
PJHW
PJ
FRQWLHQQHQW
DPLGRQGHPDwV
KGUR[SURSOFHOOXORVH
KGUR[SURSOPpWKOFHOOXORVH
PRQRK GUDWHGHODFWRVH VWpDUDWHGH
PDJQpVLXPFHOOXORVH
PLFURFULVWDOOLQH SROpWK OqQHJOFRO
HWGLR[GHGHWLWDQH
,QJUpGLHQWVDGGLWLRQQHOVGHV
FRPSULPpV GH
PJ
ODTXH GDOXPLQLXPFRQWHQDQWGH
O LQGLJRWLQH
,QJUpGLHQWVDGGLWLRQQHOV GHV
FRPSULPpVGH
PJ
R[GHGHIHU URXJH ± WHLQWH RUDQJpH
HWR[GHGHIHU MDXQH
3RU SOVGHUHQVHLJQHPHQWV YHLOOH
FRQV
OWHUOD VHFWLRQ )RUPHVSDUPDFH WLT HV
FRPSRVLWLRQHW
FRQGLWLRQQHPHQW
,1 , 7,216 (7 86*(/,1,48(
GXOHV
F LSpL
EOSSp
2/1=3,1( RODQ]DSLQH HVWLQGLTXp SRXUOHWUDLWHPHQW GHVSKDVHV DLJXsV HW
OHWUDLWHPHQW
GHQWUHWLHQGH ODVFKL]RSKUpQLH HWGHVWURXEOHVSVFKRWLTXHV
DSSDUHQWpV/HVHVVDLVFOLQLTXHVRQW
GpPRQWUpTXHORODQ]DSLQHDPpOLRUDLW j ODIRLV OHV VPSWPHVSRVLWLIVHW OHV
VPSWPHVQpJDWLIV
2QDGpPRQWUpTXH ODPpOLRUDWLRQ FOLQLTXHSHUVLVWDLW GXUDQWXQDQGH
WUDLWHPHQW FRQWLQXFKH]OHV
SDWLHQWVD DQWUpSRQGX j ORODQ]DSLQHORUVGX WUDLWHPHQWGHOD SKDVHDLJXs
0RQRJUDS LHGHSURGLW 2/ 1
3,1(
3DJH
GH
EOELS O
L
2/